KLRK1 and neoplasm: Future research in this field should address this issue and assess effects on NKG2D ligands more systematically and in vivo, as frequently used in vitro models don't reflect the complexity in the interplay of tumor cells, tumor microenvironment and NKG2D expressing immune cells which are also impacted by the treatment.